NCT03371316 (ViaShield) is a NA clinical trial of ViaShield in Hemicraniectomies, sponsored by Globus Medical Inc.

Who is sponsoring NCT03371316?

NCT03371316 is sponsored by Globus Medical Inc.

What drugs are being tested in NCT03371316?

Interventions in NCT03371316: ViaShield.

What condition does NCT03371316 study?

NCT03371316 studies Hemicraniectomies.

Is NCT03371316 still recruiting?

NCT03371316 is currently withdrawn. Last updated 15 February 2018.

Last reviewed 2018-02-15 · How we verify

NCT03371316: ViaShield

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies

Withdrawn NA Last updated 15 February 2018

What this trial tests

NA trial testing ViaShield in Hemicraniectomies. Withdrawn.

Timeline

20 January 2018

Primary endpoint
30 January 2018

30 January 2018

Quick facts

Lead sponsor	Globus Medical Inc
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	20 January 2018
Primary completion	30 January 2018
Estimated completion	30 January 2018

Drugs / interventions tested

ViaShield — full drug profile →

Conditions studied

Hemicraniectomies — all drugs for Hemicraniectomies →

Sponsor

Globus Medical Inc — full company profile →

Who can join

18 and older, any sex, with Hemicraniectomies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to demonstrate that ViaShield™ amnion patch is effective in preventing fibroblast activity and hence soft tissue adhesions after a hemicraniectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Globus Medical Inc trials

Trials by the same sponsor.

NCT06298812 — REFLECT Scoliosis System Post Approval Study · NA · recruiting
NCT04088383 — Amnios™ RT Outcomes Study · NA · completed
NCT03162666 — Patient Outcomes Using an Expandable Spacer · withdrawn
NCT02184520 — A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System · NA · terminated
NCT01861899 — Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03371316 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Globus Medical Inc
Last refreshed: 15 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03371316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing